Filing Details
- Accession Number:
- 0002019976-24-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-03 16:31:00
- Reporting Period:
- 2024-11-18
- Accepted Time:
- 2024-12-03 16:31:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1217234 | Caredx Inc. | CDNA | Services-Medical Laboratories (8071) | 943316839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2019976 | Adam Jeffrey Novack | C/O Caredx, Inc. 8000 Marina Boulevard Brisbane CA 94005 | Secretary And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-18 | 3,656 | $21.65 | 115,255 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-18 | 807 | $22.00 | 114,448 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-18 | 1,071 | $22.00 | 113,377 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-25 | 365 | $24.00 | 113,012 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-25 | 858 | $24.00 | 112,154 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.94, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.